IFRS 2 Share-based Payment

Conceptual Framework Linkage

Why share options are a genuine expense

The Conceptual Framework requires an expense to be recognised whenever an entity CONSUMES an economic resource in exchange for goods or services received – receiving employee SERVICE in exchange for share options is no different from paying cash wages, even though no cash changes hands. IFRS 2 exists specifically to stop share-based remuneration being treated as a "free" cost that bypasses the SOPL.

HOW IFRS 2 MAPS TO THE FRAMEWORK

Expense recognition – services received in exchange for equity instruments are recognised as an expense as those services are CONSUMED, matching employee service to the vesting period Faithful representation – omitting share-based payment expense from the SOPL (as was historically common under some old GAAPs) would materially understate an entity's true remuneration cost Substance over form – the SAME underlying instrument (a share option) can create either an EQUITY increase or a LIABILITY, depending on whether the entity or the counterparty controls the settlement method

IFRS 2 was historically controversial precisely because it forced companies to recognise a genuine P&L expense for something many previously treated as having "no cost" – a direct triumph of the Framework's expense-recognition principle over a long-standing accounting convention.

Measurement principles applied

IFRS 2's measurement basis differs fundamentally depending on classification – a direct consequence of whether the ultimate settlement obligation is fixed (equity) or variable (liability).

ClassificationMeasurement basis

Equity-settledFair value AT GRANT DATE, fixed and never remeasured thereafter

Cash-settledFair value REMEASURED at each reporting date until settlement

Qualitative characteristics in action: fixing equity-settled fair value at grant date reflects faithful representation of the ORIGINAL bargain struck with employees – remeasuring it later (as if it were a liability) would introduce volatility unrelated to the entity's actual obligation, since equity holders bear share price risk directly, not the entity.

Scope & Applicability

What IFRS 2 covers

IFRS 2 applies to all share-based payment transactions, whether the entity can identify specifically some or all of the goods/services received – including transactions with EMPLOYEES and with OTHER PARTIES (e.g. suppliers, consultants) settled in cash, other assets, or equity instruments.

THREE CATEGORIES

Equity-settled – the entity receives goods/services and settles by issuing its own equity instruments Cash-settled – the entity incurs a liability for amounts based on the price (or value) of its equity instruments Transactions with a choice of settlement – either the entity or the counterparty can choose whether settlement is in cash or equity instruments

IFRS 2 explicitly EXCLUDES share-based payments to acquire goods as part of a business combination consideration under IFRS 3 (specific IFRS 3 rules apply instead), and transactions within the scope of IAS 41 or IAS 2 for the contribution of assets in specific circumstances.

Key definitions you must know

Grant date

The date at which the entity and the counterparty AGREE to a share-based payment arrangement, having a shared understanding of the terms and conditions – for arrangements subject to approval, this is the date approval is obtained.

Vesting conditions

Conditions that determine whether the entity receives the services entitling the counterparty to receive cash, other assets, or equity instruments – comprising SERVICE conditions and PERFORMANCE conditions (market and non-market).

Vesting period

The period during which all specified vesting conditions of a share-based payment arrangement are to be satisfied.

Grant date fair value

The fair value of an equity instrument at the grant date, determined using an option pricing model where market prices are not directly available – used and FIXED for equity-settled transactions.

Equity-Settled – Recognition & Grant Date Fair Value (with worked example)

The core recognition mechanics

Total expense = Number of instruments expected to vest × Grant date fair value per instrument, recognised on a STRAIGHT-LINE basis over the vesting period, with a corresponding CREDIT to equity

The entity recognises goods/services received (and the corresponding increase in equity) DIRECTLY as an expense (for employee/service arrangements), unless the goods/services qualify for recognition as an asset under another Standard.

Worked example – basic 3-year equity-settled option grant

Example 1: Share options with a 3-year service condition

On 1 January 20X1, an entity grants 100 share options each to 50 employees, conditional on 3 years' continued service. Grant date fair value: $12 per option. At the end of Year 1, the entity estimates 5 employees will leave before vesting (45 expected to vest); by the end of Year 2, this estimate is revised to 6 leavers (44 expected to vest); by the end of Year 3, 43 employees actually remain and receive their options.

Year 1: cumulative expense = 45 × 100 × $12 × (1/3) = $18,000
Year 2: cumulative expense = 44 × 100 × $12 × (2/3) = $35,200; Year 2 charge = 35,200 − 18,000 = $17,200
Year 3: cumulative expense = 43 × 100 × $12 × (3/3) = $51,600; Year 3 charge = 51,600 − 35,200 = $16,400

The estimate of the NUMBER of instruments expected to vest is REVISED each period based on the best available information – but the GRANT DATE FAIR VALUE PER OPTION ($12) is NEVER revised, even if the entity's share price moves dramatically.

Vesting Conditions – Market vs Non-Market (with worked example)

The critical distinction – WHERE the condition is reflected

Condition typeTreatment

Service conditionAffects the NUMBER of instruments expected to vest, re-estimated each period

Non-market performance condition(e.g. a profit target) ALSO affects the NUMBER expected to vest, re-estimated each period, just like a service condition

Market condition(e.g. a specific SHARE PRICE target, or total shareholder return relative to a peer index) is built INTO the GRANT DATE FAIR VALUE calculation itself, using an option pricing model – NEVER re-estimated, and expense is recognised REGARDLESS of whether the market condition is ultimately achieved

Example 2: Market condition (share price target) – expense recognised even if the target is missed

An entity grants options vesting only if the share price reaches $25 within 3 years (a market condition). The grant date fair value, already reflecting the probability of achieving this target via an option pricing model, is $8 per option. By the end of Year 3, the share price target was NOT achieved, and the options lapse unexercised.

The FULL expense based on the original $8 grant date fair value is STILL recognised over the vesting period, EVEN THOUGH the options never actually vested – because a market condition is treated as having ALREADY been factored into fair value at grant date, its failure does NOT reverse previously recognised expense.

This is one of the most frequently tested and counter-intuitive rules in IFRS 2: failure to satisfy a MARKET condition does NOT result in reversal of expense already recognised, unlike a service or non-market performance condition, which DOES adjust the number expected to vest (and can reduce cumulative expense to nil if nobody ultimately vests).

Modifications, Cancellations & Forfeitures

Modifications – a floor, never a reduction

If a modification INCREASES the fair value of the instruments granted (e.g. reducing the exercise price), the entity includes the INCREMENTAL fair value granted in the measurement of the amount recognised for services received. If a modification DECREASES total fair value, the entity CONTINUES to recognise the services received based on the ORIGINAL grant date fair value, as if the modification had not occurred – a decrease in fair value is simply IGNORED for expense purposes.

Cancellations & forfeitures

Forfeiture (failure to meet a NON-market vesting condition, e.g. an employee leaves) → treated as if the grant had NEVER been made; cumulative expense already recognised is REVERSED Cancellation by the entity (e.g. buying out unvested options) → treated as an ACCELERATION of vesting; any amount NOT yet recognised is recognised IMMEDIATELY

Cancellation is treated very differently from forfeiture: cancellation ACCELERATES the remaining expense into the current period, while forfeiture (for failing a non-market/service condition) REVERSES the expense already booked.

Cash-Settled Share-based Payment (with worked example)

Share appreciation rights – remeasured every period

For cash-settled transactions, the entity measures the goods/services acquired, and the LIABILITY incurred, at the FAIR VALUE of the liability. Until the liability is settled, the entity REMEASURES the fair value of the liability at EACH reporting date and at the date of settlement, with any changes in fair value recognised in profit or loss for the period.

Example 3: Share appreciation rights (SARs) over 3 years

An entity grants 200 cash-settled SARs to each of 100 employees, vesting after 3 years of service, entitling each employee to a cash payment based on the share price increase since grant. Fair value of each SAR: Year 1 end $5, Year 2 end $7, Year 3 end (vesting date) $9. 90 employees remain employed through vesting.

Year 1: 90 × 200 × $5 × (1/3) = $30,000 (liability and expense)
Year 2: cumulative = 90 × 200 × $7 × (2/3) = $84,000; Year 2 charge = 84,000 − 30,000 = $54,000
Year 3: cumulative = 90 × 200 × $9 × (3/3) = $162,000; Year 3 charge = 162,000 − 84,000 = $78,000

Remuneration expense

SOPL

Liability – SARs

SOFP

Unlike equity-settled awards, BOTH the number expected to vest AND the fair value per unit are re-estimated/remeasured every single period – a genuinely different, higher-volatility accounting outcome.

Transactions with a Choice of Settlement

Counterparty has the choice

Where the COUNTERPARTY has the right to choose whether a share-based payment transaction is settled in cash or equity instruments, the entity has granted a COMPOUND financial instrument, split into a DEBT component (the counterparty's right to demand cash) and an EQUITY component – measured similarly to IAS 32's compound instrument split.

Entity has the choice

Where the ENTITY has the choice of settlement, the entity determines whether it has a PRESENT OBLIGATION to settle in cash (in which case cash-settled accounting applies), or otherwise accounts for the transaction as EQUITY-SETTLED – the classification hinges on whether a genuine cash obligation exists in substance.

Employee Share Purchase Plans & Group Share-based Payment Transactions

Discounted employee share purchase plans

Where employees can purchase shares at a DISCOUNT to market price, the discount itself is generally accounted for as a share-based payment expense, UNLESS the plan qualifies for a specific practical exemption for plans with no meaningful discount and no vesting-type conditions attached.

Group share-based payment arrangements

Where a PARENT grants rights to its own equity instruments to employees of a SUBSIDIARY, the subsidiary recognises the SERVICES received as an expense (with a corresponding increase in EQUITY, treated as a capital contribution from the parent), and the parent recognises the increase in equity in its OWN or consolidated financial statements, as appropriate.

Disclosure Requirements

Required disclosures

NATURE & EXTENT DISCLOSURES

A description of each type of share-based payment arrangement, including general terms and conditions (vesting requirements, maximum term, method of settlement) Number and weighted average exercise prices of share options – outstanding at the start/end of the period, granted, forfeited, exercised, and expired during the period Weighted average share price at the date of exercise for options exercised during the period

MEASUREMENT & IMPACT DISCLOSURES

How the fair value of goods/services received, or the fair value of equity instruments granted, was determined (inputs to the option pricing model used) The total expense recognised in the period for share-based payment transactions For cash-settled arrangements: total carrying amount of the liability at the end of the period, and the intrinsic value of vested liabilities

Critical Judgments & Estimates

Where management judgement matters most

SIGNIFICANT JUDGEMENTS

Classifying a condition as market vs non-market (a critical distinction determining whether it's built into fair value or re-estimated) Distinguishing forfeiture from cancellation, given their opposite accounting effects Determining whether the entity has a present obligation to settle in cash in a choice-of-settlement arrangement

SIGNIFICANT ESTIMATES

Fair value of options/other equity instruments at grant date, using an appropriate option pricing model (e.g. Black-Scholes, binomial) and its inputs (volatility, expected life, risk-free rate) Estimated number of instruments expected to vest, revised each period for service and non-market performance conditions Fair value of cash-settled liabilities at each subsequent reporting date

Option pricing model INPUTS (particularly expected volatility and expected life) can be significantly judgemental, especially for newly listed or unlisted entities without a long trading history – small changes in these assumptions can materially affect the total remuneration expense recognised.

IFRS vs US GAAP – Key Differences

Comparison – IFRS 2 vs US GAAP (ASC 718)

FeatureIFRS (IFRS 2)US GAAP

Core grant-date fair value approachFair value at grant, fixed for equity-settledVery similar approach – broadly converged following a joint standard-setting effort

Forfeiture estimatesEstimate forfeitures and revise each periodAlso permits either estimating forfeitures OR accounting for them as they actually occur, a POLICY CHOICE not available under IFRS 2

Market condition failureExpense recognised regardless of whether the market condition is achievedSimilarly, expense is not reversed for failure to achieve a market condition – largely converged

Modification decreasing fair valueOriginal grant date fair value continues to be used; decrease ignoredBroadly similar treatment, converged in substance

IFRS 2 and ASC 718 are among the more converged pairs of standards, following a dedicated joint project – the main practical difference is the forfeiture ESTIMATION POLICY CHOICE available under US GAAP (estimate vs actual) that IFRS 2 does not offer, since IFRS mandates the estimation approach.

Statement Mapping – Where Every Share-based Payment Event Lands

Comprehensive event-to-statement mapping table

Event / transactionStatement(s) affectedNotes

Equity-settled expense recognised each periodSOPL EquityCredited to a separate equity reserve, based on fixed grant date fair value

Forfeiture (service/non-market condition not met)SOPL EquityCumulative expense reversed, as if the grant never occurred

Market condition not achieved–No reversal; expense already recognised remains

Cancellation by the entitySOPL EquityRemaining unrecognised expense accelerated immediately

Exercise of vested optionsEquityReserve transferred to share capital/premium; no SOPL impact

Cash-settled expense recognised each periodSOPL SOFPLiability remeasured to fair value each period

Settlement of a cash-settled awardSOFPLiability derecognised; cash paid

Cash paid on settlementCash Flow StatementOperating or financing activities outflow, per policy

Terms, option pricing inputs, movement reconciliationNotesMandatory disclosure

Related Standards – Cross-Reference Map

How IFRS 2 connects across the IFRS body of literature

StandardNature of the connection

IAS 32Supplies the compound instrument split-accounting logic used for choice-of-settlement arrangements where the counterparty controls settlement

IFRS 3Share-based payment awards issued as part of business combination consideration follow IFRS 3's own specific rules rather than IFRS 2's general model

IAS 33Employee share options are potential ordinary shares, tested for dilution via the treasury stock method in diluted EPS

IAS 24Share-based payment awards to key management personnel must be disclosed as part of KMP compensation, by category

IAS 12Tax deductions for share-based payment often differ from the accounting expense, creating temporary differences and deferred tax consequences

IFRS 13Supplies general fair value measurement concepts underlying option pricing model inputs, where relevant

Quick-Reference Glossary

Market condition

A condition related to the market price of the entity's equity instruments (e.g. achieving a specified share price) – built into grant date fair value, never re-estimated.

Non-market performance condition

A condition related to something OTHER than a market price (e.g. a profit or sales target) – affects the NUMBER of instruments expected to vest, re-estimated each period.

Intrinsic value

The difference between the fair value of shares a counterparty has the right to subscribe for (or receive) and the price it must pay for those shares.

Share appreciation right (SAR)

A cash-settled instrument entitling the holder to a cash payment based on the increase in the entity's share price over a specified period.

Expected term / expected life

The expected period an option/SAR is expected to be outstanding before exercise, a key input to the option pricing model used to determine fair value.

Grant date fair value

The fair value of an equity instrument at the grant date, fixed for equity-settled transactions and never remeasured.

Financial statement key

BS Balance sheet

IS Income statement

SE Statement of changes in equity

OCI Other comprehensive income

SCF Statement of cash flows

History & Development

Feb-2004

In February 2004 the International Accounting Standards Board (Board) issued IFRS 2 Share-based Payment.

Jan-2008

The Board amended IFRS 2 to clarify its scope in January 2008 and to incorporate the guidance contained in two related Interpretations (IFRIC 8 Scope of IFRS 2 and IFRIC 11 IFRS 2-Group and Treasury Share Transactions) in June 2009.

Jun-2016

In June 2016 the Board issued Classification and Measurement of Share-based Payment Transactions (Amendments to IFRS 2). This amended IFRS 2 to clarify the accounting for (a) the effects of vesting and non-vesting conditions on the measurement of cash-settled share-based payments; (b) share-based payment transactions with a net settlement feature for withholding tax obligations; and (c) a modification to the terms and conditions of a share-based payment that changes the classification of the transaction from cash-settled to equity-settled.

May-2011

IFRS 10 Consolidated Financial Statements